Preparation, characterization, and performance of magnetic iron-carbon composite microparticles for chemotherapy

Biomaterials

Volumn 21, Issue 14, 2000, Pages 1411-1420

  Rudge, S R ^a   Kurtz, T L ^a   Vessely, C R ^a   Catterall, L G ^a   Williamson, D L ^b  

^a FeRx Incorporated   (United States)

^b Department of Geology and Geological Engineering   (United States)

Author keywords

Activated carbon; Doxorubicin; Magnetic targeting

Indexed keywords

ACTIVATED CARBON; ADSORPTION ISOTHERMS; CHEMOTHERAPY; COMPOSITE MATERIALS; DIFFERENTIAL THERMAL ANALYSIS; INTERFACES (MATERIALS); MAGNETIC MATERIALS; MICROSCOPIC EXAMINATION; MOSSBAUER SPECTROSCOPY; SURFACE PROPERTIES; WATER ABSORPTION; X RAY DIFFRACTION ANALYSIS;

DOXORUBICIN; MAGNETIC MICROCARRIERS; MAGNETIC TARGETING;

BIOMATERIALS;

ACTIVATED CARBON; CARBON; DOXORUBICIN; IRON;

ADSORPTION; ARTICLE; CELL LINE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG TARGETING; MAGNETIC FIELD; MAGNETISM; MICROPARTICLE; MICROSCOPY; MOSSBAUER SPECTROSCOPY; PARTICLE SIZE; PHYSICAL PARAMETERS; PRIORITY JOURNAL; SCANNING FORCE MICROSCOPY; SURFACE PROPERTY; WATER VAPOR; X RAY DIFFRACTION;

ADENOCARCINOMA; BIOCOMPATIBLE MATERIALS; BREAST NEOPLASMS; CARBON; DOXORUBICIN; DRUG CARRIERS; DRUG THERAPY; FEMALE; HUMANS; IRON; MAGNETICS; MICROSCOPY, ELECTRON, SCANNING; PRESSURE; SPECTROSCOPY, MOSSBAUER; TUMOR CELLS, CULTURED;

EID: 0034110246     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00006-5     Document Type: Article

References (27)

1. Pouliquen D, Chouly C, Magnetic microcarriers for medial applications. In: Arshady R, editor. Microspheres microcapsules & liposomes, vol. 2, medical and biotechnology applications. London: Citus Books, 1999. p. 343-82.
2. Widder K.J., Senyei A.E., Scarpelli D.G. Magnetic microspheres. a model system for site specific drug delivery in vivo Proc Soc Exp Biol Med. 58:1978;141-146.
3. Widder K.J., Morris R.M., Poore G.A., Howards D.P., Senyei A.E. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin. total remission in Yoshida sarcoma-bearing rats Eur J Cancer Clin Oncol. 19:1983;135-139.
4. Gupta P.K., Hung C.T. Magnetically controlled targeted micro-carrier systems. Magn Controlled Drug Delivery. 44:1989;175-186.
5. Pulfer S.K., Gallo J.M. Targeting magnetic microspheres to brain tumors. Hafeli U., Schütt W., Teller J., Zborowski M. Scientific and clinical applications of magnetic carriers. 1997;445-455 Plenum Press, New York.
6. Lubbe A.S., Bergemann C. Selected preclinical and first clinical experiences with magnetically targeted 4′-epidoxorubicin in patients with advanced solid tumors. Hafeli U., Schütt W., Teller J., Zborowski M. Scientific and clinical applications of magnetic carriers. 1997;457-480 Plenum Press, New York.
7. Chen H., Langer R.S. Magnetically-responsive polymerized liposomes as potential oral delivery vehicles. Pharm Res. 14:1997;537-540.
8. Muller-Schulte D., Fussl F., Lueken H., De Cuyper M. A new AIDS therapy approach using magnetoliposomes. Hafeli U., Schütt W., Teller J., Zborowski M. Scientific and clinical applications of magnetic carriers. 1997;517-526 Plenum Press, New York.
9. Allen L.M., Kent T., Wolfe C., Ficco C., Johnson J. MTC, a magnetically targetable drug carrier for paclitaxel. Hafeli U., Schütt W., Teller J., Zborowski M. Scientific and clinical applications of magnetic carriers. 1997;481-494 Plenum Press, New York.
10. Goodwin S.C., Peterson C.L., Hoh C., Bittner C.A. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy. J Magn Magn Mater. 194:1999;132-139.
11. Bittner CA, Goodwin SC, Peterson CL. Single-dose toxicity study of MTC-doxorubicin administered by hepatic intra-arterial infusion in swine using magnetic targeting. Inv Rad 1999, submitted for publication.
12. United States Pharmacopeia. Activated Charcoal 1999;24:371.
13. United States Pharmacopeia. Dehydrated Alcohol 1999;24:59.
14. United States Pharmacopeia. Doxorubicin Hydrochloride Injection 1999;24:607.
15. Benjamin J.S., Volin T.E. The mechanism of mechanical alloying. Metall Trans. 5:1974;1929-1934.
16. Benjamin J.S. Mechanical alloying. Scientific American. 234:1976;108-116.
17. Stookey L.L. A new spectrophotometer reagent for iron. Anal Chem. 42:1970;779-781.
18. Theakston H.M., Bandi W.R. Spectrophotometric determination of trace amounts of phosphorous in high-alloy steel. Anal Chem. 38:1966;1764-1767.
19. Campbell S.J., Gleiter H. Mössbauer effect studies of nanostructured materials. Long J., Grandjean F. Mossbauer spectroscopy applied to magnetism and materials science. vol. 1:1993;241 Plenum Press, New York.
20. Massalski TB et al. (Eds.). Binary alloy phase diagrams, 2nd ed. Materials Park, OH: ASM International, 1990.
21. Tanaka T., Nasu S., Ishihara K.N., Shingu P.H. Mechanical alloying of the high carbon Fe-C system. J Less-Commom Metals. 171:1991;237-247.
22. Kuznetsov A.A., Harutyunyan A.R., Dobrinsky E.K., Filippov V.I., Malenkov A.G., Vanin A.F., Kuznetsov O.A. Ferro-carbon particles, preparation and clinical applications. Hafeli U., Schütt W., Teller J., Zborowski M. Scientific and clinical applications of magnetic carriers. 1997;379-389 Plenum Press, New York.
23. Minko T., Kopeckova P., Kopecek J. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. J Control Rel. 59:1999;133-148.
24. CRC handbook of chemistry and physics, 77th edn. Cleveland, OH: CRC Press, 1996.
25. Bozorth R.M. Materials for permanent magnets. Ferromagnetism. 1951;364-370 D. Van Nostrand Company Inc. New York.
26. Cullity B.D. Introduction to magnetic materials. 1972;Addison-Wesley Publishing Company, Reading MA.
27. Craik D. Magnetism principles and applications. 1995;Wiley, Chichester, NY.